- Omega Diagnostics said it had raised £635k to provide working capital as the company continues to develop its HIV testing kit.

New shares in the company were issued at 10p each.

'We are pleased with the support shown from our existing shareholders as the company progresses with its strategic review,' chief executive Colin King said.

'These funds will help with working capital as the Group looks to exploit the opportunity available to them surrounding Visitect CD4 testing at the point-of-care level with the aim of helping people living with HIV globally.'

At 8:25am: [LON:ODX] Omega Diagnostics Group PLC share price was +0.3p at 10.15p

Story provided by